Azelaic acid foam

DRUG2 trials

Sponsors

LEO Pharma, Padagis LLC

Conditions

Papulopustular RosaceaRosacea

Phase 1

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

CompletedNCT01257919

LEO PharmaPapulopustular Rosacea

Start: 2011-01-31End: 2011-03-31Updated: 2023-06-09

Phase 3

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

CompletedNCT02800148

Padagis LLCRosacea

Start: 2016-11-30End: 2017-10-31Updated: 2021-11-08